Zobrazeno 1 - 10
of 855
pro vyhledávání: '"Heinz, Ludwig"'
Autor:
Charlotte Pawlyn, Fredrik H. Schjesvold, David A. Cairns, L. J. Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos, Jacob Laubach, Katja Weisel, Heinz Ludwig, S. Vincent Rajkumar, Pieter Sonneveld, Graham Jackson, Gareth Morgan, Paul G. Richardson
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Measurement of overall survival (OS) remains the gold standard for interpreting the impact of new therapies for multiple myeloma in phase 3 trials. However, as outcomes have improved, it is increasingly challenging to use OS as the primary e
Externí odkaz:
https://doaj.org/article/186d300a7c3d4b47adaec4bd25b20ac5
Autor:
Heinz Ludwig, Thomas Melchardt, Ilvy Schweitzer, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Niklas Zojer, Laurenz Schöffmann, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Wöll, Reinhard Ruckser, Boris Bozic, Maria‐Theresa Krauth, Andreas Petzer, Clemens Schmitt, Sigrid Machherndl‐Spandl, Hermine Agis, Michael Fillitz, Song‐Yau Wang, Stefan Knop, Richard Greil
Publikováno v:
eJHaem, Vol 5, Iss 3, Pp 494-504 (2024)
Abstract Understanding the impact of induction and maintenance therapy on patients’ quality of life (QoL) is important for treatment selection. This study aims to compare patient‐reported QoL between patients treated with KTd or KRd induction the
Externí odkaz:
https://doaj.org/article/024099f3e64d40079ea0f35121c1b82f
Autor:
Noopur Raje, Kenneth Anderson, Hermann Einsele, Yvonne Efebera, Francesca Gay, Sarah P. Hammond, Alexander M. Lesokhin, Sagar Lonial, Heinz Ludwig, Philippe Moreau, Krina Patel, Karthik Ramasamy, Maria-Victoria Mateos
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-17 (2023)
Abstract Bispecific antibodies (BsAbs) are emerging as an important novel class of immunotherapeutic agents for the treatment of multiple myeloma (MM), and are set to be more widely used in clinical practice. However, this new class of therapies is a
Externí odkaz:
https://doaj.org/article/9cc1745b33414a3f8f0955517dbe626e
Autor:
Fredrik H. Schjesvold, Heinz Ludwig, Sossana Delimpasi, Pawel Robak, Daniel Coriu, Waldemar Tomczak, Ludek Pour, Ivan Spicka, Meletios-Athanasios Dimopoulos, Tamas Masszi, Natalia G. Chernova, Anna Sandberg, Marcus Thuresson, Stefan Norin, Nicolaas A. Bakker, Maria-Victoria Mateos, Paul G. Richardson, Pieter Sonneveld
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/1f56d919430f4d45b42e8c04712262cb
Autor:
Simone Oerlemans, Belle H. de Rooij, Christine Bennink, Lars Bullinger, Annemiek Broijl, Mattia D’Agostino, Edward Laane, Maria Teresa Lupo-Stanghellini, Aurore Perrot, Ruth Wester, Viorica Cursaru, Hans Scheurer, Jan Vesseur, Mehul Dalal, Rohini Sen, Tanja Stamm, Heinz Ludwig, Pieter Sonneveld
Publikováno v:
Haematologica, Vol 109, Iss 6 (2024)
Externí odkaz:
https://doaj.org/article/1276e2d91fb54db5a87fd9e7f62f9c3c
Autor:
Heinz Ludwig, Thomas Melchardt, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Christoph Tinchon, Niklas Zojer, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Woell, Reinhard Ruckser, Boris Bozic, Maria Theresa Krauth, Andreas Petzer, Clemens A. Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Michael Fillitz, Song-Yau Wang, Stefan Knop, Bruno Paiva, Richard Greil
Publikováno v:
HemaSphere, Vol 7, p e55498d5 (2023)
Externí odkaz:
https://doaj.org/article/6331fd869261467da7450cd271583f31
Autor:
Hélène Asnagli, Norbert Minet, Christina Pfeiffer, Eef Hoeben, Rebecca Lane, David Laughton, Louise Birch, Geraint Jones, Andrew Novak, Andrew E. Parker, Heinz Ludwig, Alain Fischer, Sylvain Latour, Philip A. Beer
Publikováno v:
HemaSphere, Vol 7, Iss 4, p e864 (2023)
Lymphoma is the most common hematological malignancy and is among the 10 most prevalent cancers worldwide. Although survival has been improved by modern immunochemotherapeutic regimens, there remains a significant need for novel targeted agents to tr
Externí odkaz:
https://doaj.org/article/94c683a95284402c9f04f59bf749bdad
Publikováno v:
EClinicalMedicine, Vol 58, Iss , Pp 101910- (2023)
Summary: Background: Biomarker-defined patients with smoldering multiple myeloma (SMM) were included in the diagnostic category of multiple myeloma (MM) by the International Myeloma Working Group (IMWG) in 2014. This includes ≥60% bone marrow plasm
Externí odkaz:
https://doaj.org/article/8d3802c38ee7469b8f756f00281f4b70